FDA Panel Says Side Effects of Vivus Weight Loss Drug Outweigh Benefits

Published July 18, 2010

FDA panel says side effects of Vivus weight loss drug outweigh benefits
GAITHERSBURG, MD. – A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug’s side effects outweigh its ability to help patients lose weight.
Read more on Minneapolis-St. Paul Star Tribune